Literature DB >> 10472249

The protease-antiprotease battle in the cystic fibrosis lung.

I M Balfour-Lynn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10472249      PMCID： PMC1297020          DOI： 10.1177/014107689909237S05

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  52 in total

1.  Rapid inactivation of alpha1-protease inhibitor (alpha1-antitrypsin) by elastase.

Authors:  J S Baumstark; C T Lee; R J Luby
Journal:  Biochim Biophys Acta       Date:  1977-06-10

2.  Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies.

Authors:  R De Water; L N Willems; G N Van Muijen; C Franken; J A Fransen; J H Dijkman; J A Kramps
Journal:  Am Rev Respir Dis       Date:  1986-05

3.  High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.

Authors:  M Delcroix; X Kurz; D Walckiers; M Demedts; R Naeije
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

4.  Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.

Authors:  N G McElvaney; B Doujaiji; M J Moan; M R Burnham; M C Wu; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1993-10

5.  Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis.

Authors:  M W Konstan; R W Walenga; K A Hilliard; J B Hilliard
Journal:  Am Rev Respir Dis       Date:  1993-10

6.  Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis.

Authors:  T P Dean; Y Dai; J K Shute; M K Church; J O Warner
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

7.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep.

Authors:  A S Carver; M A Dalrymple; G Wright; D S Cottom; D B Reeves; Y H Gibson; J L Keenan; J D Barrass; A R Scott; A Colman
Journal:  Biotechnology (N Y)       Date:  1993-11

9.  Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Authors:  K S Jagger; D R Bahner; R L Warren
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

10.  Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.

Authors:  A Gillissen; P Birrer; N G McElvaney; R Buhl; C Vogelmeier; R F Hoyt; R C Hubbard; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1993-08
View more
  12 in total

Review 1.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.

Authors:  P Perez; J Adriaansen; C M Goldsmith; C Zheng; B J Baum
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

3.  Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.

Authors:  Silvia M Caceres; Kenneth C Malcolm; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Donna L Bratton; Samuel M Moskowitz; Jane L Burns; Jerry A Nick
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.

Authors:  Travis S Walker; Kerry L Tomlin; G Scott Worthen; Katie R Poch; Jonathan G Lieber; Milene T Saavedra; Michael B Fessler; Kenneth C Malcolm; Michael L Vasil; Jerry A Nick
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome.

Authors:  Jennifer R Peters-Hall; Kristy J Brown; Dinesh K Pillai; Amarel Tomney; Lindsay M Garvin; Xiaofang Wu; Mary C Rose
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

6.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

7.  X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.

Authors:  Weijun Huang; Yasufumi Yamamoto; Yi Li; Dengfeng Dou; Kevin R Alliston; Robert P Hanzlik; Todd D Williams; William C Groutas
Journal:  J Med Chem       Date:  2008-03-05       Impact factor: 7.446

Review 8.  Highlights of a workshop to discuss targeting inflammation in cystic fibrosis.

Authors:  Katharine H Banner; Hugo De Jonge; Stuart Elborn; Ellena Growcott; Erich Gulbins; Mike Konstan; Rick Moss; Chris Poll; Scott H Randell; Adriano G Rossi; Lorraine Thomas; David Waltz
Journal:  J Cyst Fibros       Date:  2008-11-20       Impact factor: 5.482

9.  Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers.

Authors:  Chendi Niu; Yi Du; Igor A Kaltashov
Journal:  Int J Mass Spectrom       Date:  2021-02-14       Impact factor: 1.986

10.  Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy.

Authors:  Quinn M Parks; Robert L Young; Katie R Poch; Kenneth C Malcolm; Michael L Vasil; Jerry A Nick
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.